Botanical species · safety record

Onosma hispida

The EFSA Compendium of Botanicals holds 2 constituent measurements for Onosma hispida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Onosma hispida Wall. ex G. Don.

2Constituent measurements
0Safety records
1Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Onosmin a1
  • Onosmin b1

Plant parts

  • Live plants2

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Onosmin aLive plantsSolvent extraction1000 Microgram/kilogramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Onosmin bLive plantsSolvent extraction1300 Microgram/kilogramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ahmad, I., Nawaz, SA., Afza, N., Malik, A., Fatima, I., Khan, SB., Ahmad, M., Choudhary, MI. Isolation of onosmins A and B, lipoxygenase inhibitors from Onosma hispida. CHEMICAL & PHARMACEUTICAL BULLETIN, 2005, vol. 53, no. 8, p. 907-910. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue